Inactive Instrument

News Hospira, Inc.

Stocks

US4410601003

Pharmaceuticals

End-of-day quote NYSE
- ^USD	-

15-08-04	Hospira : Pfizer wins EU approval for $15 billion Hospira buy	RE
15-07-27	Allergan : Mylan independence from Teva's embrace comes with a price	RE

All News

Mentions Relevance

15-08-27	Hospira : Announces First Installation of Plum 360™ Infusion System With Hospira MedNet™	PU
15-08-27	Hospira : Announces First Installation of Plum 360(TM) Infusion System With Hospira MedNet(TM)	PR
15-08-21	Hospira : Expert committee BACKS Hospira’s InflectraTM	PU
15-08-20	Hospira : Charleston Area Medical Center Integrates Smart Pump Technology to Advance Patient Safety	PR
15-08-19	Hospira : TGA Approves First mAb Biosimilar	PR
15-08-13	Hospira : Applauds UK's NICE for Issuing Adoption Resource to Help Drive the Introduction of Biosimilars	PU
15-08-04	Hospira : Pfizer wins EU approval for $15 billion Hospira buy	RE
15-07-16	Hospira : Announces U.S. Launch of Generic Bivalirudin for Injection	PR
15-07-15	Hospira : to Announce Second-Quarter 2015 Results on July 29, 2015	PR
15-07-14	Hospira : Pfizer offers concessions in bid to win EU okay for Hospira deal	RE
15-06-10	Hospira : New results from first real-world study show comparable effectiveness and safety of Hospira's Inflectra™ (infliximab) in patients with rheumatic diseases switched from reference infliximab, Remicade™	PU
15-06-10	Hospira : New results from first real-world study show comparable effectiveness and safety of Hospira's Inflectra(TM) (infliximab) in patients with rheumatic diseases switched from reference infliximab, Remicade(TM)	PR
15-06-02	Hospira : ANVISA Approves First Infliximab Biosimilar in Brazil	PU
15-05-20	Hospira : Alliance for Health Reform Bring Food and Drug Administration, Industry Experts Together to Discuss the Future of Biosimilars in the United States	PR
15-05-13	Hospira : Shareholders Approve Merger of Hospira and Pfizer at Special Meeting	PR
15-05-01	Hospira : Statement On FDA's Final Biosimilar Guidance Documents	PU
15-04-24	Hospira : Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation	PR
15-04-13	Hospira : Hope for Greater Access for Patients to Biosimilar Medicines	PR
15-04-07	Hospira : to Announce First-Quarter 2015 Results on April 28, 2015	PR
15-03-30	Hospira : INFLECTRA(TM) (Infliximab) Now Available in Canada	PR
15-03-27	Hospira : Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen	PR
15-03-06	Hospira : Inflectra™ (infliximab) patient registry reports interim results in the treatment of inflammatory bowel disease	PU
15-03-06	Hospira : Statement on FDA Approval of the First Biosimilar in the United States	PR
15-02-19	Hospira : Inflectra(TM) (infliximab) patient registry reports interim results in the treatment of inflammatory bowel disease	PR
15-02-16	Hospira : launches first biosimilar monoclonal antibody (mAb) Inflectra™ (infliximab) in major European markets	PU